<p>Danny Heng joins to tour through VEGF TKI drug development from sorafenib to tivozanib and everything in between.</p>

Episode 435: The History of IO in RCC - Part 1

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London